| Initial LMWH/VKAa | 95% Confidence Interval | Extended Placebob | 95% Confidence Interval | Extended VKAsc | 95% Confidence Interval |
---|---|---|---|---|---|---|
Relative risks | ||||||
Recurrent VTE and VTE-related death | 1.18 | 0.83–1.66 | 5.33 | 3.02–9.40 | 0.42 | 0.16–1.06 |
Major bleed | 3.26 | 1.84–5.79 | 2.07* | 0.38–11.24 | 7.7 | 1.09–76.40 |
CRNM bleed | 2.09 | 1.66–2.63 | 0.78 | 0.43–1.40 | 3.84 | 1.55–9.38 |
Other treatment discontinuation | 1.07§ | 0.85–1.35§ | - |  | 1.33 | 0.75–1.87 |